Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 29;5(4):e007702.
doi: 10.1136/bmjopen-2015-007702.

Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval

Karynsa Cetin  1 , Christian Fynbo Christiansen  2 , Claus Sværke  2 , Jacob Bonde Jacobsen  2 , Henrik Toft Sørensen  2
Affiliations

Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval

Karynsa Cetin et al. BMJ Open. .

Abstract

Objectives: Since population-based data on prognostic factors affecting survival in patients with breast cancer with bone metastasis (BM) are currently limited, we conducted this nationwide retrospective cohort study to examine the prognostic role of disease stage at breast cancer diagnosis and length of BM-free interval (BMFI).

Setting: Denmark.

Participants: 2427 women with a breast cancer diagnosis between 1997 and 2011 in the Danish Cancer Registry and a concurrent or subsequent BM diagnosis in the Danish National Registry of Patients.

Primary and secondary outcome measures: Survival (crude) based on Kaplan-Meier method and mortality risk (crude and adjusted for age, year of diagnosis, estrogen receptor status and comorbidity) based on Cox proportional hazards regression analyses by stage of disease at breast cancer diagnosis and by length of BMFI (time from breast cancer to BM diagnosis), following patients from BM diagnosis until death, emigration or until 31 December 2012, whichever came first.

Results: Survival decreased with more advanced stage of disease at the time of breast cancer diagnosis; risk of mortality during the first year following a BM diagnosis was over two times higher for those presenting with metastatic versus localised disease (adjusted HR=2.12 (95% CI 1.71 to 2.62)). With respect to length of BMFI, survival was highest in women with a BMFI <1 year (ie, in those who presented with BM at the time of breast cancer diagnosis or were diagnosed within 1 year). However, among patients with a BMFI ≥1 year, survival increased with longer BMFI (1-year survival: 39.9% (95% CI 36.3% to 43.6%) for BMFI 1 to <3 years and 52.6% (95% CI 47.4% to 57.6%) for BMFI ≥5 years). This pattern was also observed in multivariate analyses.

Conclusions: Stage of disease at breast cancer diagnosis and length of BMFI appear to be important prognostic factors for survival following BM.

PubMed Disclaimer

References

    1. Jemal A, Bray F, Center MM et al. . Global cancer statistics. CA Cancer J Clin 2011;61:69–90. 10.3322/caac.20107 - DOI - PubMed
    1. Engholm G, Ferlay J, Christensen N et al. . NORDCAN––a Nordic tool for cancer information, planning, quality control and research. Acta Oncol 2010;49:725–36. 10.3109/02841861003782017 - DOI - PubMed
    1. Engholm G, Ferlay J, Christensen N et al. . NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic countries, version 5.3. Association of the Nordic cancer registries. Danish Cancer Society; (accessed 25 Apr 2013).
    1. Jensen AO, Jacobsen JB, Norgaard M et al. . Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark. BMC Cancer 2011;11:29 10.1186/1471-2407-11-29 - DOI - PMC - PubMed
    1. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006;12:6243s–9s. 10.1158/1078-0432.CCR-06-0931 - DOI - PubMed

Publication types

LinkOut - more resources